Suchergebnisse - "Sarilumab"

PubPharm (306)

71

UGT1A1 genetic variants are associated with increases in bilirubin levels in rheumatoid arthritis patients treated with sarilumab

enthalten in: The pharmacogenomics journal | 2022

von Lin, N. | Damask, A. | Boyapati, A. | +12

72

Sarilumab Administration in COVID-19 Patients : Literature Review and Considerations

enthalten in: Infectious disease reports | 2022

von Marino, A. | Munafò, A. | Augello, E. | +7

73

Pharmacological treatment of COVID-19 : an opinion paper

enthalten in: Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia | 2022

von García-Lledó, A. | Gómez-Pavón, J. | González Del Castillo, J. | +12

74

Management of hepatitis B virus reactivation due to treatment of COVID-19

enthalten in: Hepatology international | 2022

von Yip, T. | Gill, M. | Wong, G. | +1

75

Drug dosing in hospitalized obese patients with COVID-19

enthalten in: Critical care (London, England) | 2022

von Barletta, J. | Erstad, B.

76

Drug dosing in hospitalized obese patients with COVID-19

enthalten in: Critical care | 2022

von Barletta, J. | Erstad, B.

77

Drug dosing in hospitalized obese patients with COVID-19

enthalten in: Critical care | 2022

von Barletta, J. | Erstad, B.

78

Efficacy and safety of sarilumab in the early treament of hospitalized patients with mild-moderate neumonia and COVID19 infection versus standard of care : Efficacy and safety of sarilumab in the early treament of hospitalized patients with mild-moderate neumonia and COVID19 infection versus standard of care - SARICOVID

enthalten in: WHO International Clinical Trials Registry Platform | 2022

79

Management of hepatitis B virus reactivation due to treatment of COVID-19

enthalten in: Hepatology international | 2022

von Yip, T. | Gill, M. | Wong, G. | +1

80

Management of hepatitis B virus reactivation due to treatment of COVID-19

enthalten in: Hepatology international | 2022

von Yip, T. | Gill, M. | Wong, G. | +1